109 related articles for article (PubMed ID: 2554710)
1. Effects of calcium antagonists on lipids and atherosclerosis.
Bernini F; Catapano AL; Corsini A; Fumagalli R; Paolétti R
Am J Cardiol; 1989 Nov; 64(17):129I-133I; discussion 133I-134I. PubMed ID: 2554710
[TBL] [Abstract][Full Text] [Related]
2. Calcium antagonists and atherosclerosis. Experimental evidence.
Catapano AL
Eur Heart J; 1997 Jan; 18 Suppl A():A80-6. PubMed ID: 9049542
[TBL] [Abstract][Full Text] [Related]
3. The antiatherogenic effects of calcium antagonists.
Keogh AM; Schroeder JS
Am J Hypertens; 1991 Jul; 4(7 Pt 2):512S-518S. PubMed ID: 1654938
[TBL] [Abstract][Full Text] [Related]
4. Effect of lacidipine on cholesterol esterification: in vivo and in vitro studies.
Bernini F; Canavesi M; Bernardini E; Scurati N; Bellosta S; Fumagalli R
Br J Pharmacol; 1997 Nov; 122(6):1209-15. PubMed ID: 9401788
[TBL] [Abstract][Full Text] [Related]
5. Focus on anti-atherosclerotic therapy.
Bernini F; Paoletti R
Eur J Epidemiol; 1992 May; 8 Suppl 1():104-6. PubMed ID: 1505646
[TBL] [Abstract][Full Text] [Related]
6. Calcium antagonists and cholesteryl ester metabolism in macrophages.
Bernini F; Bellosta S; Didoni G; Fumagalli R
J Cardiovasc Pharmacol; 1991; 18 Suppl 10():S42-5. PubMed ID: 1725002
[TBL] [Abstract][Full Text] [Related]
7. Decreased aortic early atherosclerosis and associated risk factors in hypercholesterolemic hamsters fed a high- or mid-oleic acid oil compared to a high-linoleic acid oil.
Nicolosi RJ; Woolfrey B; Wilson TA; Scollin P; Handelman G; Fisher R
J Nutr Biochem; 2004 Sep; 15(9):540-7. PubMed ID: 15350986
[TBL] [Abstract][Full Text] [Related]
8. Calcium antagonists increase the amount of mRNA for the low-density lipoprotein receptor in skin fibroblasts.
Eckardt H; Filipovic I
Artery; 1991; 18(4):168-83. PubMed ID: 1651691
[TBL] [Abstract][Full Text] [Related]
9. Anti-atherosclerotic and plasma lipid lowering effects of the novel calcium blocker with alpha 1-adrenoceptor antagonistic activity, monatepil, in high cholesterol diet-fed Japanese Macaca fuscata monkeys.
Miyazaki M; Hosoki K; Okunishi H; Ishii K; Ikeno A; Okazaki Y
Arzneimittelforschung; 1994 Mar; 44(3):288-97. PubMed ID: 8192692
[TBL] [Abstract][Full Text] [Related]
10. The role of microscopy in understanding atherosclerotic lysosomal lipid metabolism.
Jerome WG; Yancey PG
Microsc Microanal; 2003 Feb; 9(1):54-67. PubMed ID: 12597787
[TBL] [Abstract][Full Text] [Related]
11. Calcium channel blockers enhance cholesteryl ester hydrolysis and decrease total cholesterol accumulation in human aortic tissue.
Etingin OR; Hajjar DP
Circ Res; 1990 Jan; 66(1):185-90. PubMed ID: 2153060
[TBL] [Abstract][Full Text] [Related]
12. Calcium channel blockers and atherosclerosis.
Henry PD
J Cardiovasc Pharmacol; 1990; 16 Suppl 1():S12-5. PubMed ID: 1706008
[TBL] [Abstract][Full Text] [Related]
13. Antiatherogenic properties of calcium antagonists. State of the art.
Weinstein DB; Heider JG
Am J Med; 1989 Apr; 86(4A):27-32. PubMed ID: 2653028
[TBL] [Abstract][Full Text] [Related]
14. A review of calcium antagonists and atherosclerosis.
Keogh AM; Schroeder JS
J Cardiovasc Pharmacol; 1990; 16 Suppl 6():S28-35. PubMed ID: 1707112
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of cholesterol accumulation in the arterial wall.
Zilversmit DB
Am J Cardiol; 1975 Apr; 35(4):559-66. PubMed ID: 164111
[TBL] [Abstract][Full Text] [Related]
16. [Effects of calcium antagonists on carbohydrate and lipid metabolism].
Preobrazhenskiĭ DV; Fomichev VI; Afanas'ev AIa
Kardiologiia; 1992 Apr; 32(4):84-9. PubMed ID: 1405247
[No Abstract] [Full Text] [Related]
17. Effects of calcium antagonists and adrenergic antihypertensive drugs on plasma lipids and cellular cholesterol metabolism.
Krone W; Müller-Wieland D; Nägele H; Behnke B; Greten H
J Cardiovasc Pharmacol; 1987; 10 Suppl 10():S199-202. PubMed ID: 2455133
[TBL] [Abstract][Full Text] [Related]
18. Lipoproteins and atherosclerosis.
Kita T; Ishii K; Yokode M; Kume N; Nagano Y; Otani H; Arai H; Ueda Y; Kawai C
Jpn Circ J; 1990 Sep; 54(9):1226-32. PubMed ID: 2176246
[No Abstract] [Full Text] [Related]
19. Antiperoxidative actions of calcium antagonists and atherogenesis.
Henry PD
J Cardiovasc Pharmacol; 1991; 18 Suppl 1():S6-10. PubMed ID: 1723459
[TBL] [Abstract][Full Text] [Related]
20. Calcium antagonists as antiatherogenic agents.
Henry PD
Ann N Y Acad Sci; 1988; 522():411-9. PubMed ID: 3288054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
